Reuters Science News Summary

Following is a summary of current science news briefs. Alphabet's GV leads funding in gene editing company Verve Therapeutics

GV, Alphabet Inc's venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases. Gene editing therapies are seen to have huge scope in treating a range of diseases but none are currently approved. Additionally, concerns about safety and the permanent harmful effects the editing could have on humans persist. Bat-winged dinosaur was intriguing detour in evolution of flight

A fossil unearthed in northeastern China of a feathered dinosaur a bit bigger than a blue jay that possessed bat-like wings represents a remarkable but short-lived detour in the evolution of flight and the advent of birds, scientists said on Wednesday. The dinosaur, named Ambopteryx longibrachium, lived 163 million years ago during the Jurassic Period and took flight with membranous wings made of skin supported by a long, pointed wrist bone, dramatically different from the distinctive feathered wings of birds.